Tariffs

News

Trump sets course for 100%, then 200%, tariffs on generics

Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.

News

US launches probe of German 'underpayment' for medicines

A Section 301 probe by the US Trade Representative into Germany's medicine pricing and reimbursement policies raises the threat of punitive tariffs.

News

Lilly inflates US facility investment spending by $4.5bn

Having already committed last year to capital investments of $27 billion in the US to ward off the threat of tariffs, Eli Lilly has upped the ante.

News

AbbVie makes record investment in North Carolina plant

AbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.

News

US pharma tariffs of up to 100% finalised by Trump

Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.

News

Threat of Trump's pharma tariffs looms again

The Trump administration is said to be preparing to announce tariffs of up to 100% on some pharmaceutical imports.

Trump sets course for 100%, then 200%, tariffs on generics

US launches probe of German 'underpayment' for medicines

Lilly inflates US facility investment spending by $4.5bn

AbbVie makes record investment in North Carolina plant

US pharma tariffs of up to 100% finalised by Trump

Threat of Trump's pharma tariffs looms again

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

Tariffs

Editor's Picks